PMV Pharma upsizes IPO by 60%, to now raise up to $211.8 million

/ / News

PMV Pharmaceuticals Inc. has upsized its initial public offering by 60%, as the oncology company now looks to raise up to $211.8 million. The company is now offering 11.765 million shares in the IPO, up from 7.350 million, while the IPO’s expected pricing range remains at between $16 and $18 a share. If the underwriters of the offering exercise options to buy up to an additional 1.76 million shares to cover overallotments, the company could raise up to $243.5 million. The company is looking to go public at a time that the Renaissance IPO ETF has rallied 60.7% year to date, while the S&P 500 has gained 1.4%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.